Procaine Induces Epigenetic Changes in HCT116 Colon Cancer Cells

Colon cancer is the third most commonly diagnosed cancer in the world, and it is the major cause of morbidity and mortality throughout the world. The present study aimed at treating colon cancer cell line (HCT116) with different chemotherapeutic drug/drug combinations (procaine, vorinostat “SAHA,” s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabit, Hussein, Samy, Mariam B., Said, Osama A. M., El-Zawahri, Mokhtar M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098101/
https://www.ncbi.nlm.nih.gov/pubmed/27843649
http://dx.doi.org/10.1155/2016/8348450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098101/
https://www.ncbi.nlm.nih.gov/pubmed/27843649
http://dx.doi.org/10.1155/2016/8348450

Ejemplares similares